STO-609 (acetate)
- Product Name
- STO-609 (acetate)
- CAS No.
- 1173022-21-3
- Chemical Name
- STO-609 (acetate)
- Synonyms
- CS-2405;PubChem ID: 16760660;STO-609 acetate salt;STO-609;STO 609;STO609;STO-609 acetate, CaM-KK inhibitor;7-oxo-7H-benzo[de]benzo[4,5]imidazo[2,1-a]isoquinoline-3-carboxylic acid;7H-Benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid, 7-oxo-, acetate (1:1);7-Oxo-7H-benzo[de]benzo[4,5]imidazo[2,1-a]isoquinoline-3-carboxylic Acid Acetate (1:1)
- CBNumber
- CB53152750
- Molecular Formula
- C21H14N2O5
- Formula Weight
- 374.35
- MOL File
- 1173022-21-3.mol
STO-609 (acetate) Property
- Melting point:
- >300 °C
- storage temp.
- 2-8°C
- solubility
- Soluble in DMSO (up to 10 mg/ml).
- form
- Yellow solid.
- color
- Yellow
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
- Precautionary statements
-
P280Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- S1318
- Product name
- STO-609-acetic acid
- Purity
- ≥95%(HPLC),solid
- Packaging
- 5mg
- Price
- $210
- Updated
- 2025/07/31
- Product number
- S1318
- Product name
- STO-609-acetic acid
- Purity
- ≥95% (HPLC), solid
- Packaging
- 25MG
- Price
- $562
- Updated
- 2025/07/31
- Product number
- 15325
- Product name
- STO-609 (acetate)
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 15325
- Product name
- STO-609 (acetate)
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $86
- Updated
- 2024/03/01
- Product number
- 15325
- Product name
- STO-609 (acetate)
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $153
- Updated
- 2024/03/01
STO-609 (acetate) Chemical Properties,Usage,Production
Description
STO-609 (1173022-21-3) is a selective inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki = 80 and 15 ng/ml for inhibition of CaM-KKα and CaM-KKβ respectively).1 Binds to the? ATP-binding site.2 Displays > 80-fold selectivity over CaMK1, CaMK2, CaMK4, MLCK, PKC, PKA and p42 MAPK. Important tool for probing distinct CaMK pathways in LTP.3 Reduces starvation-induced autophagosomal membrane formation.4 Reverses age-associated decline in bone mass.5 Stimulates osteoblast formation, inhibits osteoclast differentiation.6
Uses
STO-609 is a cell-permeable inhibitor of calcium/calmodulin-dependent kinase kinases (CaMKK) isoforms CaMKKα and CaMKKβ. It is used to evaluate the action of CaMKK isoforms both in vitro and in cells.
General Description
STO-609 reduces tumorigenicity of liver cancer cells in vivo. TO-609 reduces the activation of AMP (adenosine monophosphate)-activated protein kinase (AMPK) by ionomycin in a dose dependant manner.
Biochem/physiol Actions
Selective Ca2+/Calmodulin-dependent protein kinase kinase (CaM-KK) antagonist. Inhibits CamKKa and CaMKKb with Ki = 80 and 15 ng/mL, respectively. Does not inhibit downstream CaM kinases (CaMKI and CaMKIV).
storage
Room temperature (desiccate)
References
[1] H. TOKUMITSU. STO-609, a Specific Inhibitor of the Ca2+/Calmodulin-dependent Protein Kinase Kinase*[J]. The Journal of Biological Chemistry, 2002, 46 1: 15813-15818. DOI:10.1074/jbc.m201075200
[2] HIROSHI TOKUMITSU. A single amino acid difference between alpha and beta Ca2+/calmodulin-dependent protein kinase kinase dictates sensitivity to the specific inhibitor, STO-609.[J]. The Journal of Biological Chemistry, 2003, 278 13: 10908-10913. DOI:10.1074/jbc.m213183200
[3] ROGER L REDONDO. Synaptic tagging and capture: differential role of distinct calcium/calmodulin kinases in protein synthesis-dependent long-term potentiation.[J]. Journal of Neuroscience, 2010: 4981-4989. DOI:10.1523/jneurosci.3140-09.2010
[4] SIMON G PFISTERER. Ca2+/calmodulin-dependent kinase (CaMK) signaling via CaMKI and AMP-activated protein kinase contributes to the regulation of WIPI-1 at the onset of autophagy.[J]. Molecular Pharmacology, 2011, 80 6: 1066-1075. DOI:10.1124/mol.111.071761
[5] ZACHARY J. PRITCHARD . Inhibition of CaMKK2 reverses age-associated decline in bone mass[J]. Bone, 2015, 75: Pages 120-127. DOI:10.1016/j.bone.2015.01.021
[6] RACHEL L CARY. Inhibition of Ca2+/Calmodulin–Dependent Protein Kinase Kinase 2 Stimulates Osteoblast Formation and Inhibits Osteoclast Differentiation[J]. Journal of Bone and Mineral Research, 2013, 28 7: 1599-1610. DOI:10.1002/jbmr.1890
[7] TOSHIYA MATSUKAWA. Upregulation of skeletal muscle PGC-1α through the elevation of cyclic AMP levels by Cyanidin-3-glucoside enhances exercise performance.[J]. Scientific Reports, 2017: 44799. DOI:10.1038/srep44799
STO-609 (acetate) Preparation Products And Raw materials
Raw materials
Preparation Products
STO-609 (acetate) Suppliers
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- +1 (732)236-3202
- sales@cckinase.com
- Country
- United States
- ProdList
- 2738
- Advantage
- 58
- Tel
- tp@aladdinsci.com
- Country
- United States
- ProdList
- 52923
- Advantage
- 58
- Tel
- +1-781-999-5354;
- support@targetmol.com
- Country
- United States
- ProdList
- 39035
- Advantage
- 58
- Tel
- --
- Fax
- --
- sales@apexbt.com
- Country
- United States
- ProdList
- 6251
- Advantage
- 58
- Tel
- --
- Fax
- --
- sales@focusbiomolecules.com
- Country
- United States
- ProdList
- 1284
- Advantage
- 58
- Tel
- --
- Fax
- --
- us.orders@abcam.com
- Country
- United States
- ProdList
- 6001
- Advantage
- 50
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81